Cargando…
A doxycycline- and light-inducible Cre recombinase mouse model for optogenetic genome editing
The experimental need to engineer the genome both in time and space, has led to the development of several photoactivatable Cre recombinase systems. However, the combination of inefficient and non-intentional background recombination has prevented thus far the wide application of these systems in bi...
Autores principales: | Vizoso, Miguel, E. J. Pritchard, Colin, Bombardelli, Lorenzo, van den Broek, Bram, Krimpenfort, Paul, Beijersbergen, Roderick L., Jalink, Kees, van Rheenen, Jacco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616875/ https://www.ncbi.nlm.nih.gov/pubmed/36307419 http://dx.doi.org/10.1038/s41467-022-33863-z |
Ejemplares similares
-
Diverse transcriptional regulation and functional effects revealed by CRISPR/Cas9-directed epigenetic editing
por: Vizoso, Miguel, et al.
Publicado: (2021) -
Cre-recombinase-associated toxicity highlights limitations of genome editing
Publicado: (2013) -
Reproducible doxycycline-inducible transgene expression at specific loci generated by Cre-recombinase mediated cassette exchange
por: Wong, Ee Tsin, et al.
Publicado: (2005) -
The Development of an AAV-Based CRISPR SaCas9 Genome Editing System That Can Be Delivered to Neurons in vivo and Regulated via Doxycycline and Cre-Recombinase
por: Kumar, Namrata, et al.
Publicado: (2018) -
A single-chain and fast-responding light-inducible Cre recombinase as a novel optogenetic switch
por: Duplus-Bottin, Hélène, et al.
Publicado: (2021)